Cineworld’s share price is falling again! I’d rather buy these 2 UK shares in my Stocks and Shares ISA

You can keep the Cineworld share price as far as I’m concerned. I’m much more interested in buying these UK shares in my ISA for 2021.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s hardly a shock to see the Cineworld Group (LSE: CINE) share price slipping again in recent hours. The UK share fell in end-of-week trading after news emerged that the release of the latest James Bond flick was being delayed again due to Covid-19. It’s now set to hit screens in October.

The latest 007 outing, No Time To Die, is arguably the most high-profile casualty of mass cinema closures. But it’s not the only money-spinning title whose release date has been put back again in recent days. Other theatre fillers subject to additional delays into 2021 include the next Ghostbusters, Peter Rabbit and Cinderella adventures.

This adds an extra problem for Cineworld and its debt-heavy balance sheet. The cinema giant is already in huge danger as Covid-19 lockdowns keep its UK theatres closed. The UK share has enough money to last until May following fresh fundraising in November. But soaring infection rates mean that its projectors are unlikely to crank into life again any time soon. A worsening US crisis might cause it to keep its Regal theatres in the States shuttered as well.

Road sign warning of a risk ahead

2 better UK shares I’d rather buy today

I sold my holdings in Cineworld a couple of months ago as fears over its existence hit fever pitch. And while its price has rocketed since then, I fear that the cinema chain could still go all the way to zero.

I’d much rather buy other UK shares in my Stocks and Shares ISA today. Here are a couple that are on my shopping list.

#1: Ryanair Holdings

Budget flyer Ryanair is, like Cineworld, still suffering as efforts to control Covid-19 keep its planes grounded. Indeed, in recent sessions the Irish flyer downscaled its full-year flight forecasts in response to fresh travel restrictions across some of its European markets.

But this UK share — unlike the aforementioned cinema chain — has the balance sheet strength to allow it to ride out the crisis. As the boffins at Morgan Stanley note, Ryanair has ample liquidity to fund cash losses if recovery takes longer.” Airlines remain a risky investment, but its considerable financial strength will also let it ramp up capacity faster than its rivals when its markets begin to open up again. I think this puts it in pole position to make big profits again.

#2: Barratt Developments

I’d also much rather invest in housebuilders like Barratt Developments than Cineworld. Indeed, I decided to hold on to my shares in the FTSE 100 firm when I sold my holdings in the cinema chain. And I don’t think I’ll be regretting my decision.

Traditionally, UK shares like Barratt take a huge hit when economic conditions deteriorate. And it’s quite possible that the housebuilders could see sales slip as Britain moves into a double-dip recession. But I think that market conditions will remain strong  enough for the Footsie firm and its peers to still make decent profits. Low interest rates and government loan schemes, allied with a huge shortage of properties entering the market, should keep new-build home demand soaring.

Royston Wild owns shares of Barratt Developments. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

3 S&P 500 growth stocks that could make index funds looks silly over the next 5 years

Edward Sheldon believes these three high-flying S&P 500 stocks have the potential to smash the market over the next five…

Read more »

Investing Articles

Here’s how to start building a passive income portfolio worth £2k a month in 2026

Dr James Fox believes there's never a better time to start a passive income ISA portfolio than today. Here's how…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

How much do you need in an ISA to target £1,000 of monthly passive income?

Dr James Fox outlines the strategy for building passive income in an ISA and one stock that could help propel…

Read more »

Investing Articles

Will the S&P 500 crash in 2026?

The S&P 500 delivered impressive gains in 2025, but valuations are now running high. Are US stocks stretched to breaking…

Read more »

Teenage boy is walking back from the shop with his grandparent. He is carrying the shopping bag and they are linking arms.
Investing Articles

How much do you need in a SIPP to generate a brilliant second income of £2,000 a month?

Harvey Jones crunches the numbers to show how investors can generate a high and rising passive income from a portfolio…

Read more »

Investing Articles

Will Lloyds shares rise 76% again in 2026?

What needs to go right for Lloyds shares to post another 76% rise? Our Foolish author dives into what might…

Read more »

Investing Articles

How much passive income will I get from investing £10,000 in an ISA for 10 years?

Harvey Jones shows how he plans to boost the amount of passive income he gets when he retires, from FTSE…

Read more »

Investing Articles

Down 34% in 2025 — but could this be one of the UK’s top growth stocks for 2026?

With clarity over research funding on the horizon, could Judges Scientific be one of the UK’s best growth stocks to…

Read more »